According to
the Centers for Disease Control (CDC), in 2007 approximately 227,000 men were
diagnosed with prostate cancer in the United States and approximately 29,000
died.
These
statistics show that since 1998 the incidence of this disease has either
remained level or decreased significantly.
Also, the mortality rate has decreased significantly since 1998. The reason for the reduction in diagnosis and
mortality is due to the improvements in treatment.
Prostate
cancer is the most common cancer diagnosed in men. The good news about prostate cancer, if there
ever is any good news with a diagnosis of any kind of cancer, is that it is one
of the slowest spreading cancers that you can be diagnosed with.
Because of
this, many men can live with the disease for years without having to risk the
side-effects that are inevitable with certain treatment plans.
There are
many treatments for prostate cancer with varying success rates. One of these treatments is High-Intensity
Focused Ultrasound (HIFU). HIFU is a
precise medical procedure that uses localized intense sonic energy that heats and
essentially vaporizes damaged tissue.
The good
news about using HIFU to eradicate prostate cancer is that it has a high success
rate, and a low rate of risks or side effects.
After one year, 95% of men who received HIFU treatment for prostate
cancer, remained cancer-free.
This is
great news for men with this disease because the other options, like surgery
and radiotherapy, have a higher risk of causing incontinence or impotence than
HIFU.
HIFU uses a highly-focused laser that can target an area as
small as millimeters in size which makes it a highly desirable alternative to
traditional surgery which removes a portion of the prostate. Traditional surgery can also cause sexual dysfunction
and more frequent trips to the bathroom for men.
HIFU is an excellent and successful new alternative treatment
plan for prostate cancer that will allow men to significantly improve their
quality of life.
Disclosure of Material Connection: This is a “sponsored post.” The company who sponsored it compensated me via a cash payment, gift, or something else of value to write it. Regardless, I only recommend products or services I use personally and believe will be good for my readers. I am disclosing this in accordance with the Federal Trade Commission’s 16 CFR, Part 255: “Guides Concerning the Use of Endorsements and Testimonials in Advertising.”
No comments:
Post a Comment